Cargando…

Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation

BACKGROUND: Brain-derived neurotrophic factor (BDNF) exerts beneficial effects not only on diabetic neuropathies but also on cardiovascular injury. There is argument regarding the levels of serum BDNF in patients with diabetes mellitus (DM). Because BDNF in peripheral blood is rich in platelets, thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Kazuo, Fuse, Ichiro, Iwakura, Yuriko, Sotoyama, Hidekazu, Hanyu, Osamu, Nawa, Hiroyuki, Sone, Hirohito, Takei, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299653/
https://www.ncbi.nlm.nih.gov/pubmed/28178976
http://dx.doi.org/10.1186/s12933-017-0505-y
_version_ 1782506066687295488
author Furukawa, Kazuo
Fuse, Ichiro
Iwakura, Yuriko
Sotoyama, Hidekazu
Hanyu, Osamu
Nawa, Hiroyuki
Sone, Hirohito
Takei, Nobuyuki
author_facet Furukawa, Kazuo
Fuse, Ichiro
Iwakura, Yuriko
Sotoyama, Hidekazu
Hanyu, Osamu
Nawa, Hiroyuki
Sone, Hirohito
Takei, Nobuyuki
author_sort Furukawa, Kazuo
collection PubMed
description BACKGROUND: Brain-derived neurotrophic factor (BDNF) exerts beneficial effects not only on diabetic neuropathies but also on cardiovascular injury. There is argument regarding the levels of serum BDNF in patients with diabetes mellitus (DM). Because BDNF in peripheral blood is rich in platelets, this may represent dysregulation of BDNF release from platelets. Here we focused on advanced glycation end products (AGEs), which are elevated in patients with DM and have adverse effects on cardiovascular functions. The aim of this study is to elucidate the role of AGEs in the regulation of BDNF release from human platelets. METHODS: Platelets collected from peripheral blood of healthy volunteers were incubated with various concentrations of AGE (glycated-BSA) at 37 °C for 5 min with or without BAPTA-AM, a cell permeable Ca(2+) chelator, or PP2, a potent inhibitor of Src family kinases (SFKs). Released and cellular BDNF were measured by ELISA and calculated. Phosphorylation of Src and Syk, a downstream kinase of SFKs, in stimulated platelets was examined by Western blotting and immunoprecipitation. RESULTS: AGE induced BDNF release from human platelets in a dose-dependent manner, which was dependent on intracellular Ca(2+) and SFKs. We found that AGE induced phosphorylation of Src and Syk. CONCLUSIONS: AGE induces BDNF release from human platelets through the activation of the Src-Syk-(possibly phospholipase C)-Ca(2+) pathway. Considering the toxic action of AGEs and the protective roles of BDNF, it can be hypothesized that AGE-induced BDNF release is a biological defense system in the early phase of diabetes. Chronic elevation of AGEs may induce depletion or downregulation of BDNF in platelets during the progression of DM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-017-0505-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5299653
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52996532017-02-13 Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation Furukawa, Kazuo Fuse, Ichiro Iwakura, Yuriko Sotoyama, Hidekazu Hanyu, Osamu Nawa, Hiroyuki Sone, Hirohito Takei, Nobuyuki Cardiovasc Diabetol Original Investigation BACKGROUND: Brain-derived neurotrophic factor (BDNF) exerts beneficial effects not only on diabetic neuropathies but also on cardiovascular injury. There is argument regarding the levels of serum BDNF in patients with diabetes mellitus (DM). Because BDNF in peripheral blood is rich in platelets, this may represent dysregulation of BDNF release from platelets. Here we focused on advanced glycation end products (AGEs), which are elevated in patients with DM and have adverse effects on cardiovascular functions. The aim of this study is to elucidate the role of AGEs in the regulation of BDNF release from human platelets. METHODS: Platelets collected from peripheral blood of healthy volunteers were incubated with various concentrations of AGE (glycated-BSA) at 37 °C for 5 min with or without BAPTA-AM, a cell permeable Ca(2+) chelator, or PP2, a potent inhibitor of Src family kinases (SFKs). Released and cellular BDNF were measured by ELISA and calculated. Phosphorylation of Src and Syk, a downstream kinase of SFKs, in stimulated platelets was examined by Western blotting and immunoprecipitation. RESULTS: AGE induced BDNF release from human platelets in a dose-dependent manner, which was dependent on intracellular Ca(2+) and SFKs. We found that AGE induced phosphorylation of Src and Syk. CONCLUSIONS: AGE induces BDNF release from human platelets through the activation of the Src-Syk-(possibly phospholipase C)-Ca(2+) pathway. Considering the toxic action of AGEs and the protective roles of BDNF, it can be hypothesized that AGE-induced BDNF release is a biological defense system in the early phase of diabetes. Chronic elevation of AGEs may induce depletion or downregulation of BDNF in platelets during the progression of DM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-017-0505-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-08 /pmc/articles/PMC5299653/ /pubmed/28178976 http://dx.doi.org/10.1186/s12933-017-0505-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Furukawa, Kazuo
Fuse, Ichiro
Iwakura, Yuriko
Sotoyama, Hidekazu
Hanyu, Osamu
Nawa, Hiroyuki
Sone, Hirohito
Takei, Nobuyuki
Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
title Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
title_full Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
title_fullStr Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
title_full_unstemmed Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
title_short Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
title_sort advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the src-family kinase activation
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299653/
https://www.ncbi.nlm.nih.gov/pubmed/28178976
http://dx.doi.org/10.1186/s12933-017-0505-y
work_keys_str_mv AT furukawakazuo advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation
AT fuseichiro advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation
AT iwakurayuriko advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation
AT sotoyamahidekazu advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation
AT hanyuosamu advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation
AT nawahiroyuki advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation
AT sonehirohito advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation
AT takeinobuyuki advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation